These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 31669575)

  • 1. Activation of AMPK promotes thyroid cancer cell migration through its interaction with PKM2 and β-catenin.
    Chen J; Zhou Q; Feng J; Zheng W; Du J; Meng X; Wang Y; Wang J
    Life Sci; 2019 Dec; 239():116877. PubMed ID: 31669575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of AMPK by metformin promotes renal cancer cell proliferation under glucose deprivation through its interaction with PKM2.
    Liu M; Zhang Z; Wang H; Chen X; Jin C
    Int J Biol Sci; 2019; 15(3):617-627. PubMed ID: 30745848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyruvate kinase M knockdown-induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival.
    Prakasam G; Singh RK; Iqbal MA; Saini SK; Tiku AB; Bamezai RNK
    J Biol Chem; 2017 Sep; 292(37):15561-15576. PubMed ID: 28778925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAK2-c-Myc-PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect.
    Gupta A; Ajith A; Singh S; Panday RK; Samaiya A; Shukla S
    Cell Death Dis; 2018 Aug; 9(8):825. PubMed ID: 30068946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling.
    Xie X; Huang X; Tang H; Ye F; Yang L; Guo X; Tian Z; Xie X; Peng C; Xie X
    Curr Cancer Drug Targets; 2018; 18(6):592-599. PubMed ID: 29110616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IGF-1-mediated PKM2/β-catenin/miR-152 regulatory circuit in breast cancer.
    Wen YY; Liu WT; Sun HR; Ge X; Shi ZM; Wang M; Li W; Zhang JY; Liu LZ; Jiang BH
    Sci Rep; 2017 Nov; 7(1):15897. PubMed ID: 29162853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN.
    Zheng Q; Lin Z; Xu J; Lu Y; Meng Q; Wang C; Yang Y; Xin X; Li X; Pu H; Gui X; Li T; Xiong W; Lu D
    Cell Death Dis; 2018 Feb; 9(3):253. PubMed ID: 29449541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
    Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
    Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect.
    Yang W; Zheng Y; Xia Y; Ji H; Chen X; Guo F; Lyssiotis CA; Aldape K; Cantley LC; Lu Z
    Nat Cell Biol; 2012 Dec; 14(12):1295-304. PubMed ID: 23178880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
    Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
    Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear translocation of PKM2/AMPK complex sustains cancer stem cell populations under glucose restriction stress.
    Yang YC; Chien MH; Liu HY; Chang YC; Chen CK; Lee WJ; Kuo TC; Hsiao M; Hua KT; Cheng TY
    Cancer Lett; 2018 May; 421():28-40. PubMed ID: 29408265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis.
    Zheng B; Geng L; Zeng L; Liu F; Huang Q
    Cell Signal; 2018 May; 45():122-131. PubMed ID: 29374601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyruvate kinase, muscle isoform 2 promotes proliferation and insulin secretion of pancreatic β-cells via activating Wnt/CTNNB1 signaling.
    Wang S; Yang Z; Gao Y; Li Q; Su Y; Wang Y; Zhang Y; Man H; Liu H
    Int J Clin Exp Pathol; 2015; 8(11):14441-8. PubMed ID: 26823761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like Cells.
    Zhou Z; Li M; Zhang L; Zhao H; Şahin Ö; Chen J; Zhao JJ; Songyang Z; Yu D
    Cancer Res; 2018 May; 78(9):2248-2261. PubMed ID: 29440169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKM2 inhibitor shikonin suppresses TPA-induced mitochondrial malfunction and proliferation of skin epidermal JB6 cells.
    Li W; Liu J; Zhao Y
    Mol Carcinog; 2014 May; 53(5):403-12. PubMed ID: 23255458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway.
    Xu Q; Wu N; Li X; Guo C; Li C; Jiang B; Wang H; Shi D
    Cell Death Dis; 2019 Nov; 10(12):874. PubMed ID: 31745071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue.
    Kachel P; Trojanowicz B; Sekulla C; Prenzel H; Dralle H; Hoang-Vu C
    BMC Cancer; 2015 Mar; 15():140. PubMed ID: 25880801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear translocation of PKM2 modulates astrocyte proliferation via p27 and -catenin pathway after spinal cord injury.
    Zhang J; Feng G; Bao G; Xu G; Sun Y; Li W; Wang L; Chen J; Jin H; Cui Z
    Cell Cycle; 2015; 14(16):2609-18. PubMed ID: 26151495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMPK interacts with β-catenin in the regulation of hepatocellular carcinoma cell proliferation and survival with selenium treatment.
    Park SY; Lee YK; Kim HJ; Park OJ; Kim YM
    Oncol Rep; 2016 Mar; 35(3):1566-72. PubMed ID: 26707164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
    Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
    World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.